Find clinical trials for Pancreatic Cancer in Orlando, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Orlando, FL, USA:
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Orlando, Florida, United States and 12 other locations
ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...
Phase 1, Phase 2
Lake Mary, Florida, United States and 27 other locations
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
Orange City, Florida, United States and 17 other locations
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer...
Phase 3
Orange City, Florida, United States and 116 other locations
A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.
Phase 1, Phase 2
Orlando, Florida, United States and 13 other locations
This study is an open-label, international, multi-center, Phase 1 study in adult patients with solid tumors likely to express CLDN18.2.
Phase 1
Orlando, Florida, United States and 11 other locations
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated dose and r...
Phase 1
Orlando, Florida, United States and 11 other locations
This is an open-label, non-randomized, multicenter, dose-escalation and expansion study in patients with selected solid tumors.
Phase 1
Celebration, Florida, United States and 3 other locations
(E7080/MK-7902) in participants with triple negative breast cancer (TNBC), ovarian cancer, gastric cancer, colorectal cancer...
Phase 2
Orlando, Florida, United States and 87 other locations
A Phase 1/2, open label, multi-center study to evaluate the safety, efficacy and tolerability of KY1044 as single agent and in combination with anti-...
Phase 1, Phase 2
Orlando, Florida, United States and 21 other locations
Clinical trials
Research sites
Resources
Legal